Carbidopa USP For Compounding (API)

Carbidopa USP active pharmaceutical ingredient (API) is a type of drug substance used in the manufacture of medications for the treatment of Parkinson's disease. It works by increasing the level of a chemical called dopamine in the brain, which helps to control movement and other functions affected by Parkinson's disease. Carbidopa is often used in combination with levodopa, another API, to enhance its effectiveness and reduce side effects. It is regulated by the USP, which sets standards for quality, purity, and strength of medications in the United States.

Ships in 2-4 business days.

Carbidopa is a medication used to treat Parkinson's disease by improving symptoms such as tremors, muscle stiffness, and difficulty with movement. It is also used in combination with levodopa to enhance its effects and reduce side effects. In compounding, Carbidopa USP may be used to make individualized medications tailored to meet specific patient needs, as well as to provide alternative formulations such as sublingual drops or transdermal patches. It may also be used in compounded medications for patients who have difficulty swallowing or who require a lower dose than what is commercially available.

CAS Number: 38821-49-7
Property: Light Sensitive